4.5 Article

Continuous generation of colitogenic CD4+ T cells in persistent colitis

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 38, Issue 5, Pages 1264-1274

Publisher

WILEY
DOI: 10.1002/eji.200737745

Keywords

colitis; colitogenic memory T cells; mucosal immunity

Categories

Ask authors/readers for more resources

inflammatory bowel diseases take chronic courses due to the expansion of colitogenic CD4(+) cells. However, it is unclear whether the persistent disease is driven by continuous reactivation of colitogenic memory CD4(+) cells to generate effector CD4(+) cells or by continuous generation of effector CD4(+) cells from naive cells. To clarify this issue, we performed a series of sequential adoptive transfers of Ly5.2(+) and Ly5.1(+) CD4(+)CD45RB high cells into RAG-2(-/-) mice at different time points. We show here that the secondarily transferred CD4(+)CD45RB high cells can be converted to CD4(+)CD44(high) CD62L(-)IL-7R alpha(high) effector-memory T cells even in the presence of pre-existing effector-memory CD4(+) cells. Although the total cell numbers of CD4(+) cells in established colitic mice were consistently equivalent irrespective of the number of primarily transferred cells, the ratio of primarily and secondarily transferred cells was dependent on the ratio of the transferred cell numbers, but not on the order of the transfer. Of note, we found that primarily transferred CD4(+) cells produced significantly lower amounts of IFN-gamma and IL-17 than CD4(+) cells arising from secondary transfer. In conclusion, the continuous generation of colitogenic CD4(+) cells that compensate for exhausted CD4(+) cells may be one of the mechanisms involved in the persistence of colitis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study

Kento Takenaka, Toshimitsu Fujii, Ami Kawamoto, Kohei Suzuki, Hiromichi Shimizu, Chiaki Maeyashiki, Osamu Yamaji, Maiko Motobayashi, Akira Igarashi, Ryoichi Hanazawa, Shuji Hibiya, Masakazu Nagahori, Elko Saito, Ryuichi Okamoto, Kazuo Ohtsuka, Mamoru Watanabe

Summary: This study adapted a deep neural network system (DNUC) to real-time video colonoscopy for the detection of histological mucosal inflammation in ulcerative colitis patients. The DNUC showed high sensitivity and specificity in predicting histological remission, and its endoscopic scoring was consistent with expert evaluations. The system has the potential to reduce the number of biopsies required and can be applied in various medical situations.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B

Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Yuki Tanaka, Shun Ishido, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Yuka Hayakawa, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Ryuichi Okamoto, Namiki Izumi

Summary: The aim of this study was to establish a target value of ALT level during NA treatment as a risk marker for HCC. The results showed that patients with ALT <21 IU/L at 1 year after NA initiation had a lower risk of HCC.

HEPATOLOGY RESEARCH (2023)

Article Gastroenterology & Hepatology

A case of venous stasis colitis possibly caused by eplerenone

Eiko Saito, Kazuo Ohtsuka, Ami Kawamoto, Toshimitsu Fujii, Kento Takenaka, Shuji Hibiya, Hiromichi Shimizu, Masakazu Nagahori, Shohei Tomii, Ryuichi Okamoto

Summary: A 50-year-old man presented with abdominal pain and diarrhea persisting for 8 months, after being treated for myocarditis with ulceration in the gastrointestinal tract. Biopsy confirmed CMV gastrocolitis and antiviral therapy was given. Improvement was observed after discontinuation of eplerenone.

CLINICAL JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease

Kento Takenaka, Yoshio Kitazume, Ami Kawamoto, Toshimitsu Fujii, Yumi Udagawa, Ryosuke Wanatabe, Hiromichi Shimizu, Shuji Hibiya, Masakazu Nagahori, Kazuo Ohtsuka, Hiroyuki Sato, Akihiro Hirakawa, Mamoru Watanabe, Ryuichi Okamoto

Summary: This study investigates the use of LRG as a biomarker for evaluating transmural activity in patients with Crohn's disease (CD). The results show a positive correlation between LRG levels and MRE scores, indicating that LRG is a highly accurate biomarker for detecting transmural activity in CD patients. Furthermore, high LRG levels are associated with increased risks of CD-related hospitalization, surgery, and clinical relapse.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Development and Application of Regenerative Medicine in Inflammatory Bowel Disease

Ryuichi Okamoto, Tomohiro Mizutani, Hiromichi Shimizu

Summary: This article discusses the importance of mucosal healing in patients with IBD and introduces current factor-based or cell-based treatment options. It also explores the future prospects of regenerative medicine in the treatment of IBD.

DIGESTION (2023)

Article Gastroenterology & Hepatology

Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors

Shun Kaneko, Yasuhiro Asahina, Mina Nakagawa, Miyako Murakawa, Yasunari Miyazaki, Takahiro Asakage, Shohei Fukuda, Takeshi Namiki, Yoshihito Kano, Masashi Nagata, Jun Tsuchiya, Masato Miyoshi, Fukiko Kitahata-Kawai, Sayuri Nitta, Yasuhiro Itsui, Sei Kakinuma, Ryuichi Okamoto

Summary: This study aimed to identify factors associated with immune-related liver injury (irLI) and investigate its impact on overall survival (OS) in patients treated with immune checkpoint inhibitors (ICIs). The results showed that treatment with anti-cytotoxic T-lymphocyte-associated protein-4 agents and baseline grade 1 aspartate aminotransferase/alanine aminotransferase elevation were independent predictive factors for grade >= 2 irLI. Treatment with anti-cytotoxic T-lymphocyte-associated protein-4 was the only independent predictive factor for grade >= 3 irLI. Patients who experienced any immune-related adverse events (irAEs) had a significantly longer median OS, and those with grade >= 2 irLI also had a significantly longer median OS. However, there was no significant difference in median OS between patients with grade >= 3 irLI and others.

HEPATOLOGY RESEARCH (2023)

Article Gastroenterology & Hepatology

Transmural Remission Characterized by High Biologic Concentrations Demonstrates Better Prognosis in Crohn's Disease

Kento Takenaka, Ami Kawamoto, Yoshio Kitazume, Toshimitsu Fujii, Yumi Udagawa, Hiromichi Shimizu, Shuji Hibiya, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe, Ryuichi Okamoto

Summary: This study aimed to explore the association between serum concentrations of biologics and transmural healing in patients with Crohn's disease. The results showed that patients who achieved transmural healing had a lower risk of hospitalization and surgery. Additionally, the concentration levels of drugs were found to be related to transmural healing.

JOURNAL OF CROHNS & COLITIS (2023)

Review Gastroenterology & Hepatology

Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR

Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto

Summary: Hepatitis C virus infection causes chronic liver inflammation and fibrogenesis, resulting in severe liver diseases and hepatocellular carcinoma. The presence of the virus in non-hepatic tissues can also lead to pathogenic impacts on extrahepatic systems and organs. These extrahepatic manifestations have significant effects on morbidity, mortality, and quality of life.

JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy

Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Tsubasa Nobusawa, Hiroaki Matsumoto, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi

Summary: The significance of fatty liver in patients with chronic hepatitis B receiving nucleic acid analog therapy remains unclear. This study aimed to determine if fatty liver affects the development of hepatocellular carcinoma (HCC) in patients receiving NA therapy. The results showed that fatty liver was not a significant factor for HCC development in these patients, while advanced fibrosis was found to be an important risk factor.

JOURNAL OF VIRAL HEPATITIS (2023)

Article Oncology

Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma

Shun Ishido, Kaoru Tsuchiya, Yoshihito Kano, Yutaka Yasui, Kenta Takaura, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Urara Sakurai, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi

Summary: The clinical usefulness of comprehensive genomic profiling (CGP) in patients with unresectable hepatocellular carcinoma (HCC) who received multiple systemic therapies is investigated in this study. Gene alterations were detected in all nine patients, with seven being eligible for clinical trials based on CGP results. The median number of alterations per patient was four, and blood samples were used in patients with extrahepatic metastasis. These findings provide genomic information of patients with multiple systemic therapies and highlight the utility of blood samples in patients with extrahepatic metastasis. Furthermore, the study suggests that understanding the genomic status in patients treated with multiple molecular-targeted agents could lead to the development of newer systemic agents for HCC treatment.

CANCERS (2023)

Article Physics, Applied

Effects of initial three-dimensional electron energy distribution on terahertz Bloch oscillations in a biased semiconductor superlattice

Takeya Unuma, Kosuke Ueda, Ryuichi Okamoto

Summary: We investigate how the initial energy distribution of electrons in a biased semiconductor superlattice, created by femtosecond pump pulses, affects terahertz Bloch oscillations. The emitted terahertz waveforms are well reproduced from a damped oscillation current with capacitive nature. In-plane excess energy changes the relaxation time via scattering processes, while partial use of the pump pulse spectrum reduces the temporal resolution.

APPLIED PHYSICS EXPRESS (2023)

Article Gastroenterology & Hepatology

Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment

Satoshi Watanabe, Nobuhiko Ogasawara, Sakurako Kobayashi, Sakura Kirino, Masami Inoue, Yui Hiraguri, Sayaka Nagata, Hiromichi Shimizu, Go Ito, Tomohiro Mizutani, Yasuhiro Nemoto, Kiichiro Tsuchiya, Ryuichi Okamoto, Mamoru Watanabe, Shiro Yui

Summary: This study focused on the role of sulfomucin in ulcerative colitis (UC) and found that sulfomucin production decreased in the inflammatory region of UC and increased in the distal colon and cecum of mice. Through organoids transplantation, sulfomucin secretion was restored in severely injured distal colon. This study provides a basis for the advancement of organoids transplantation therapy for refractory UC.

JOURNAL OF GASTROENTEROLOGY (2023)

Correction Gastroenterology & Hepatology

Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR (Feb, 10.1007/s00535-022-01940-1, 2023)

Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto

JOURNAL OF GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

SPONTANEOUS INFLAMMATION SPECIFICALLY IN THE ILEUM IS INDUCED BY SELECTIVE IGA DEFICIENCY

Takashi Nagaishi, Daiki Yamada, Mamoru Watanabe, Ryuichi Okamoto, Richard S. Blumberg

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

DISSECTION OF CANCER CELL PLASTICITY IN A NOVEL DEFINED CULTURE SYSTEM FOR HUMAN COLORECTAL CANCER

Nobuhiko Ogasawara, Yoshito Kano, Shinichi Yamauchi, Sakurako Kobayashi, Satoshi Watanabe, Go Ito, Tomohiro Mizutani, Hiromichi Shimizu, Mamoru Watanabe, Yusuke Kinugasa, Ryuichi Okamoto, Shiro Yui

GASTROENTEROLOGY (2022)

No Data Available